Juanli Ji

State Key Laboratory Of Silkworm Genome Biology
Chongqing, 400715, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Correction: Cao et al. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774.

Correction: Cao et al. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774.

Journal: Cells

Published: August 06, 2024

Anti-tumor activity of tigecycline: a review

Anti-tumor activity of tigecycline: a review

Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology

Published: October 08, 2021

Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer.

Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer.

Journal: International journal of molecular sciences

Published: September 17, 2021

Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET.

Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET.

Journal: Cells

Published: June 26, 2019

Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.

Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: November 06, 2017

Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.

Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.

Journal: Oncology reports

Published: December 07, 2016

[Corrigendum] Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.

[Corrigendum] Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.

Journal: Oncology reports

Published: December 07, 2016

Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.

Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.

Journal: Oncology reports

Published: November 13, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026